Prognostic Significance of Fibrotic Focus and Tumor Infiltrating Lymphocytes in Breast Cancer According to Molecular Subtypes

다국어 초록 (Multilingual Abstract)

Purpose: This study aimed to analyze the association between fibrotic focus (FF) and tumor-infiltrating lymphocytes (TILs) and to determine the prognostic significance of FF and TILs in the breast according to its molecular subtypes.
Methods: The study included patients who underwent surgical treatment for breast cancer, for whom tissue samples were available. FF within the tumor and TILs in breast cancer tissues were evaluated. Clinicopathological characteristics were reviewed from medical records.
Results: FF and TILs were present in 31.3% and 81.7% of the patients, respectively. FF and TILs showed a positive correlation. FF were significantly associated with tumor size, lymphovascular invasion, regional lymph node metastasis, and tumor stage. TILs were significantly associated with menopausal status, histologic grade, tubule formation, nuclear grade, mitosis, human epidermal growth factor receptor 2 (HER2) overexpression, molecular subtype of breast cancer, and the number of cluster of differentiation 8+ T cells. In TIL-positive cases, FF were significantly associated with tumor size, regional lymph node metastasis, extranodal extension, lymphovascular invasion, tumor stage, recurrence-free survival, and overall survival (OS). Based on HER2 overexpression status, TILs were significantly associated with tumor size, tumor necrosis, histologic grade, estrogen receptor status, and epidermal growth factor receptor expression in HER2-negative breast cancer. Further, in HER2-negative breast cancer, OS and recurrence-free survival were significantly associated with FF. The OS of FF-positive patients was significantly shorter than that of FF-negative patients.
Conclusion: Our study showed an association between FF and TIL levels in breast cancer, indicating that FF are associated with poor prognostic factors for breast cancer and poor OS, and that TILs are associated with HER2 overexpression. However, further studies are needed to elucidate the interactions between FF and TILs in breast cancer.

참고문헌 (Reference)

1 Dieci MV, "Update on tumor-infiltrating lymphocytes(TILs)in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ : a report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer" 52 : 16-25, 2018

2 Denkert C, "Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer : a pooled analysis of 3771 patients treated with neoadjuvant therapy" 19 : 40-50, 2018

3 Lin B, "Tumor-infiltrating lymphocytes : warriors fight against tumors powerfully" 132 : 110873-, 2020

4 Baghban R, "Tumor microenvironment complexity and therapeutic implications at a glance" 18 : 59-, 2020

5 Loi S, "Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer : results from the FinHER trial" 25 : 1544-1550, 2014

6 Bejarano L, "Therapeutic targeting of the tumor microenvironment" 11 : 933-959, 2021

7 Balkwill F, "The tumor microenvironment at a glance" 125 : 5591-5596, 2012

8 Boulter L, "The fibrotic and immune microenvironments as targetable drivers of metastasis" 124 : 27-36, 2021

9 Salgado R, "The evaluation of tumor-infiltrating lymphocytes(TILs)in breast cancer : recommendations by an International TILs Working Group 2014" 26 : 259-271, 2015

10 Chandler C, "The double edge sword of fibrosis in cancer" 209 : 55-67, 2019

11 Wang M, "Role of tumor microenvironment in tumorigenesis" 8 : 761-773, 2017

12 Adams S, "Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials : ECOG 2197 and ECOG 1199" 32 : 2959-2966, 2014

13 Hasebe T, "Prognostic significance of fibrotic focus in invasive ductal carcinoma of the breast : a prospective observational study" 15 : 502-516, 2002

14 Loi S, "Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy : BIG 02-98" 31 : 860-867, 2013

15 Yanai H, "Presence of myxoid stromal change and fibrotic focus in pathological examination are prognostic factors of triple-negative breast cancer : results from a retrospective single-center study" 16 : e0245725-, 2021

16 Gao ZH, "Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes : a meta-analysis" 25 (25): 1150-, 2020

17 Han W, "Oriented collagen fibers direct tumor cell intravasation" 113 : 11208-11213, 2016

18 Bozóky B, "Novel signatures of cancer-associated fibroblasts" 133 : 286-293, 2013

19 Basu A, "Immunotherapy in breast cancer : current status and future directions" 143 : 295-349, 2019

20 Wolff AC, "Human epidermal growth factor receptor 2 testing in breast cancer : American Society of Clinical Oncology/College of American Pathologists clinical practice guideline focused update" 142 : 1364-1382, 2018

21 Osipov A, "From immune checkpoints to vaccines : the past, present and future of cancer immunotherapy" 143 : 63-144, 2019

22 Hasebe T, "Fibrotic focus in infiltrating ductal carcinoma of the breast : a significant histopathological prognostic parameter for predicting the long-term survival of the patients" 49 : 195-208, 1998

23 Mujtaba SS, "Fibrotic focus in breast carcinomas : relationship with prognostic parameters and biomarkers" 20 : 2842-2849, 2013

24 Shimada H, "Fibrotic focus : an important parameter for accurate prediction of a high level of tumor-associated macrophage infiltration in invasive ductal carcinoma of the breast" 67 : 331-341, 2017

25 정영주 ; Jin-Gu Bong ; 박성환 ; 최정혜 ; 오훈규, "Expression of Leptin, Leptin Receptor, Adiponectin, and Adiponectin Receptor in Ductal Carcinoma In Situ and Invasive Breast Cancer" 한국유방암학회 14 (14): 96-103, 2011

26 Fang M, "Collagen as a double-edged sword in tumor progression" 35 : 2871-2882, 2014

27 Li Y, "Association between the degree of fibrosis in fibrotic focus and the unfavorable clinicopathological prognostic features of breast cancer" 7 : e8067-, 2019

28 He L, "Association between levels of tumor-infiltrating lymphocytes in different subtypes of primary breast tumors and prognostic outcomes : a meta-analysis" 20 : 94-, 2020

29 LeBleu VS, "A peek into cancer-associated fibroblasts: origins, functions and translational impact" 11 : dmm029447-, 2018

30 Van den Eynden GG, "A fibrotic focus is a prognostic factor and a surrogate marker for hypoxia and(lymph)angiogenesis in breast cancer : review of the literature and proposal on the criteria of evaluation" 51 : 440-451, 2007